Brief: Hofseth Biocare Q4 Adjusted EBITDA Loss NOK 26.1 Mln

Hofseth Biocare ASA

14/02/2025 07:47

Feb 14 (Reuters) - Hofseth Biocare ASA  HBC.OL :
    * Q4 ADJUSTED EBITDA LOSS NOK 26.1 MILLION VERSUS LOSS NOK
39.8
MILLION YEAR AGO
    * Q4 GROSS OPERATING REVENUE NOK 64.9M (47.4M)

Source text:  ID:nGNEtMghB 
Further company coverage:  HBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))